At Hikal, we specialize in small molecule CDMO, applying technologies such as hydrogenation, biocatalysis, and flow chemistry. This enables us to offer services from the early phase through to the commercial stage, all under both non-GMP and GMP conditions, with a strong focus on high quality and competitiveness for API and intermediates. We have extensive experience working with customers in US, Europe and Japan, and we pride ourselves on offering unique solutions to support ongoing projects. Hikal currently operates six sites in India, FDA and GMP. Our unique approach emphasizes transparency and low-carbon technologies, and we are unique in later stages of projects with efficiency and low-cost manufacturing.